NXG Nexgenrx Inc

NEXGENRX INC. (TSX VENTURE:NXG) ("NexgenRx" or the "Corporation") announces that
it has received notice from one of its clients, Accertaclaim Servicorp Inc.,
that they will not be renewing their contract with the Corporation on September
1, 2013.


Accerta, a client of the Corporation since November 2006, have taken the
strategic decision to exit the private TPA market and focus on the public
welfare dental business by purchasing their own dental claims system and
operating it in-house. It should be noted that Accerta has confirmed that this
decision is not a result of any issues with service, performance, pricing or
reliability of NexgenRx's products or services.


"We appreciate the strategic decision Accerta has taken to return to their core
dental business and our current analysis indicates that the impact to our net
income for 2013 will be approximately $100,000 (+/- 10%). Notwithstanding this
change, we are confident that with our recently introduced sales strategy and
our pipeline of prospective clients, we will continue the positive trajectory
for our business" stated Ron Loucks, President & CEO.


About NexgenRx

NexgenRx is Canada's leading independent health benefits plan administrator,
providing proprietary on-line claims adjudication and web-based solutions to
effectively manage benefits costs for plan sponsors and their members. More
information on NexgenRx can be found at www.nexgenrx.com. 


Caution Regarding Forward-Looking Statements - This news release contains
certain forward looking statements, including statements regarding the business
and anticipated financial performance of the Corporation. These statements are
subject to a number of risks and uncertainties. Actual results may differ
materially from results contemplated by the forward-looking statements. When
relying on forward-looking statements to make decisions, investors and others
should carefully consider the foregoing factors and other uncertainties and
should not place undue reliance on such forward-looking statements.


FOR FURTHER INFORMATION PLEASE CONTACT: 
NexgenRx Inc.
Ronald C. Loucks
President and CEO
416.695.3393 x801


NexgenRx Inc.
Taba Merrikh
Director of Finance
416.695.3393 x803

Nexgenrx (TSXV:NXG)
Historical Stock Chart
From May 2024 to Jun 2024

Nexgenrx (TSXV:NXG)
Historical Stock Chart
From Jun 2023 to Jun 2024